PMC:7105881 / 1515-1762 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"62","span":{"begin":44,"end":49},"obj":"Species"},{"id":"63","span":{"begin":50,"end":54},"obj":"Species"}],"attributes":[{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"Tax:9606"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"Tax:11118"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"bunit vaccines against these two pathogenic human CoVs. These subunit vaccines are introduced on the basis of full-length spike (S) protein, receptor-binding domain (RBD), non-RBD S protein fragments, and non-S structural proteins, and the potenti"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":132,"end":139},"obj":"Body_part"},{"id":"T3","span":{"begin":182,"end":189},"obj":"Body_part"},{"id":"T4","span":{"begin":222,"end":230},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"bunit vaccines against these two pathogenic human CoVs. These subunit vaccines are introduced on the basis of full-length spike (S) protein, receptor-binding domain (RBD), non-RBD S protein fragments, and non-S structural proteins, and the potenti"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T14","span":{"begin":44,"end":49},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"bunit vaccines against these two pathogenic human CoVs. These subunit vaccines are introduced on the basis of full-length spike (S) protein, receptor-binding domain (RBD), non-RBD S protein fragments, and non-S structural proteins, and the potenti"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":132,"end":139},"obj":"Chemical"},{"id":"T3","span":{"begin":182,"end":189},"obj":"Chemical"},{"id":"T4","span":{"begin":222,"end":230},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"bunit vaccines against these two pathogenic human CoVs. These subunit vaccines are introduced on the basis of full-length spike (S) protein, receptor-binding domain (RBD), non-RBD S protein fragments, and non-S structural proteins, and the potenti"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T33","span":{"begin":44,"end":49},"obj":"SP_6;NCBITaxon:9606"},{"id":"T34","span":{"begin":158,"end":164},"obj":"SO:0000417"},{"id":"T35","span":{"begin":180,"end":189},"obj":"PG_1"},{"id":"T56881","span":{"begin":44,"end":49},"obj":"SP_6;NCBITaxon:9606"},{"id":"T78790","span":{"begin":158,"end":164},"obj":"SO:0000417"},{"id":"T16061","span":{"begin":180,"end":189},"obj":"PG_1"}],"text":"bunit vaccines against these two pathogenic human CoVs. These subunit vaccines are introduced on the basis of full-length spike (S) protein, receptor-binding domain (RBD), non-RBD S protein fragments, and non-S structural proteins, and the potenti"}